Benzinga | Nov 4, 2020 04:03PM EST

Spectrum Pharmaceuticals Q3 EPS $(0.27) Beats $(0.35) Estimate

Spectrum Pharmaceuticals (NASDAQ:SPPI) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.35) by 22.86 percent. This is a 22.73 percent decrease over losses of $(0.22) per share from the same period last year.